H Meguro

453 total citations
64 papers, 356 citations indexed

About

H Meguro is a scholar working on Pharmacology, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, H Meguro has authored 64 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pharmacology, 24 papers in Epidemiology and 23 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in H Meguro's work include Antibiotics Pharmacokinetics and Efficacy (41 papers), Pharmaceutical studies and practices (16 papers) and Pneumonia and Respiratory Infections (11 papers). H Meguro is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (41 papers), Pharmaceutical studies and practices (16 papers) and Pneumonia and Respiratory Infections (11 papers). H Meguro collaborates with scholars based in Japan, United States and United Kingdom. H Meguro's co-authors include Peter F. Wright, Anne E Torrence, R Fujii, Hiroki Fujita, Rie Fujii, Kotaro Suzuki, Osamu Hanyu, Takamasa Ishii, Takanori Narita and Abe T and has published in prestigious journals such as The Journal of Immunology, Journal of Clinical Microbiology and Emerging infectious diseases.

In The Last Decade

H Meguro

56 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Meguro Japan 8 217 87 80 46 38 64 356
Jackson Gg 12 158 0.7× 92 1.1× 53 0.7× 18 0.4× 13 0.3× 28 344
Jane Democratis United Kingdom 10 330 1.5× 82 0.9× 13 0.2× 12 0.3× 19 0.5× 12 465
Ingrid K. Blomquist United States 7 172 0.8× 200 2.3× 71 0.9× 19 0.4× 33 0.9× 11 447
D. Ungheri Italy 9 202 0.9× 115 1.3× 27 0.3× 17 0.4× 4 0.1× 19 386
Maryanne Skeljo Australia 11 366 1.7× 146 1.7× 103 1.3× 17 0.4× 14 0.4× 19 570
C. R. Gregg United States 8 151 0.7× 83 1.0× 22 0.3× 154 3.3× 26 0.7× 10 365
M. Allewelt Germany 8 166 0.8× 54 0.6× 44 0.6× 15 0.3× 33 0.9× 20 515
Kenneth Kaplan United States 11 88 0.4× 113 1.3× 135 1.7× 37 0.8× 21 0.6× 15 375
Hans G. Grieble United States 12 113 0.5× 88 1.0× 40 0.5× 12 0.3× 9 0.2× 23 411
R. O. Peckinpaugh United States 10 162 0.7× 71 0.8× 13 0.2× 91 2.0× 62 1.6× 22 281

Countries citing papers authored by H Meguro

Since Specialization
Citations

This map shows the geographic impact of H Meguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Meguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Meguro more than expected).

Fields of papers citing papers by H Meguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Meguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Meguro. The network helps show where H Meguro may publish in the future.

Co-authorship network of co-authors of H Meguro

This figure shows the co-authorship network connecting the top 25 collaborators of H Meguro. A scholar is included among the top collaborators of H Meguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Meguro. H Meguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morozumi, Miyuki, Takeshi Tajima, Megumi Sakuma, et al.. (2020). Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan. Emerging infectious diseases. 26(9). 2210–2213. 16 indexed citations
2.
Okada, Takafumi, Masaaki Kobayashi, Yasuo Kondo, et al.. (2017). Immunochromatography test for rapid diagnosis of Mycoplasma pneumoniae infection. Pediatrics International. 59(10). 1123–1125. 2 indexed citations
3.
Narita, Takuma, Hiroki Fujita, Jun Koshimura, et al.. (2001). Glycemic Control Reverses Increases in Urinary Excretions of Immunoglobulin G and Ceruloplasmin in Type 2 Diabetic Patients with Normoalbuminuria. Hormone and Metabolic Research. 33(6). 370–378. 20 indexed citations
4.
Fujita, Hiroki, Takanori Narita, H Meguro, et al.. (2000). Lack of Association Between an ecNOS Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetic Patients with Proliferative Diabetic Retinopathy. Hormone and Metabolic Research. 32(2). 80–83. 29 indexed citations
5.
Fujii, R, et al.. (1996). Pharmacokinetics and clinical effects of cefozopran in pediatric patients.. PubMed. 49(1). 17–33.
6.
Fujii, R, Abe T, T. Tajima, et al.. (1995). [Pharmacokinetic and clinical studies of S-1108 in the pediatric field. Pediatric Study Group of S-1108].. PubMed. 48(7). 921–41. 3 indexed citations
8.
Fujii, Rie, et al.. (1994). [Clinical studies of arbekacin sulfate in the pediatric field].. PubMed. 47(1). 57–83. 6 indexed citations
9.
Fujii, R, H Meguro, Abe T, et al.. (1990). [Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].. PubMed. 43(1). 181–215. 5 indexed citations
10.
Fujii, R, H Meguro, Akiko Higa, et al.. (1989). Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. The Journal of Antibiotics. 42(2). 512–541. 1 indexed citations
11.
Meguro, H, Hideaki Shiraishi, Tsuyoshi Tajima, et al.. (1989). [Clinical evaluation of a new oral cephem, cefpodoxime proxetil in children].. PubMed. 42(7). 1561–70. 2 indexed citations
12.
Fujii, R, H Meguro, Akiko Higa, et al.. (1989). [Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. Pediatric Study Group of Clarithromycin].. PubMed. 42(2). 512–41. 1 indexed citations
13.
Fujii, R, T Shinozaki, H Meguro, et al.. (1988). [Appraisal of rokitamycin in the pediatric field].. PubMed. 41(6). 646–62. 1 indexed citations
14.
Meguro, H, et al.. (1988). [A case of pneumococcal meningitis resistant to beta-lactam antibiotic treatment].. PubMed. 62(7). 682–3. 4 indexed citations
15.
Fujii, R, T Shinozaki, H Meguro, et al.. (1987). [Comparative, controlled study on an ampicillin suppository (KS-R 1) with an oral form of ampicillin in urinary tract infections].. PubMed. 40(3). 476–92. 4 indexed citations
16.
Meguro, H, et al.. (1982). [Cyclocytidine therapy for the herpes-group virus infection in children. A preliminary study].. PubMed. 35(9). 2241–8. 1 indexed citations
17.
Kobayashi, Yutaka, T Haruta, R Fujii, et al.. (1981). Clinical evaluation of cefotaxime in the treatment of purulent meningitis in children.. PubMed. 4 Suppl A. 89–110. 11 indexed citations
19.
Wright, Peter F., et al.. (1978). 825 CHARACTERISTICS OF INFLUENZA B INFECTION IN INFANTS COMPARED TO CHILDREN AND YOUNG ADULTS. Pediatric Research. 12. 501–501. 1 indexed citations
20.
Wright, Peter F., H Meguro, Juliette Thompson, Anne E Torrence, & David T. Karzon. (1977). LIVE PARAINFLUENZA TYPE 3 VACCINE IN CHILDREN. Pediatric Research. 11(4). 509–509. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026